References |
1 |
THE METABOLISM OF METHYLDOPA IN HYPERTENSIVE HUMAN SUBJECTS
|
2 |
Clinical pharmacokinetics of methyldopa
|
3 |
Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label
|
4 |
Sulfate and methyldopa metabolism: metabolite patterns and platelet phenol sulfotransferase activity. Clin Pharmacol Ther. 1985 Mar;37(3):308-15.
|
5 |
The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects
|
6 |
Antihypertensive metabolites of alpha-methyldopa
|